310 related articles for article (PubMed ID: 11078946)
1. Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep.
Alvarez LI; Imperiale FA; Sánchez SF; Murno GA; Lanusse CE
Vet Parasitol; 2000 Dec; 94(1-2):75-89. PubMed ID: 11078946
[TBL] [Abstract][Full Text] [Related]
2. Modified plasma and abomasal disposition of albendazole in nematode-infected sheep.
Alvarez LI; Sánchez SF; Lanusse CE
Vet Parasitol; 1997 May; 69(3-4):241-53. PubMed ID: 9195734
[TBL] [Abstract][Full Text] [Related]
3. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep.
Alvarez LI; Sánchez SF; Lanusse CE
J Vet Pharmacol Ther; 1999 Apr; 22(2):77-86. PubMed ID: 10372592
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy.
Moreno L; Echevarria F; Muñoz F; Alvarez L; Sanchez Bruni S; Lanusse C
Exp Parasitol; 2004; 106(3-4):150-7. PubMed ID: 15172222
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica.
Alvarez LI; Mottier ML; Sánchez SF; Lanusse CE
Parasitol Res; 2001 Nov; 87(11):929-34. PubMed ID: 11728018
[TBL] [Abstract][Full Text] [Related]
6. Comparative drug systemic exposure and clinical efficacy against resistant nematodes in lambs treated with different albendazole formulations.
Suárez G; Alvarez L; Castells D; Correa O; Fagiolino P; Lanusse C
J Vet Pharmacol Ther; 2011 Dec; 34(6):557-64. PubMed ID: 21371047
[TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium.
Alvarez LI; Mottier ML; Lanusse CE
Parasitology; 2004 Jan; 128(Pt 1):73-81. PubMed ID: 15002906
[TBL] [Abstract][Full Text] [Related]
8. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
[TBL] [Abstract][Full Text] [Related]
9. Albendazole enantiomeric metabolism and binding to cytosolic proteins in the liver fluke Fasciola hepatica.
Solana H; Scarcella S; Virkel G; Ceriani C; Rodríguez J; Lanusse C
Vet Res Commun; 2009 Feb; 33(2):163-73. PubMed ID: 18726703
[TBL] [Abstract][Full Text] [Related]
10. Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfendazole and their metabolites in adult sheep.
Lanusse CE; Gascon LH; Prichard RK
J Vet Pharmacol Ther; 1995 Jun; 18(3):196-203. PubMed ID: 7674455
[TBL] [Abstract][Full Text] [Related]
11. Albendazole failure to control resistant nematodes in lambs: lack of effect of fasting-induced improvement on drug absorption.
Alvarez L; Entrocasso C; Lifschitz A; Manazza J; Ceballos L; Borda B; Lanusse C
J Parasitol; 2010 Dec; 96(6):1204-10. PubMed ID: 21158637
[TBL] [Abstract][Full Text] [Related]
12. Understanding the main route of drug entry in adult Fasciola hepatica: Further insights into closantel pharmacological activity.
Ceballos L; Canton C; Cadenazzi G; Larsen K; Virkel G; Moreno L; Fairweather I; Lanusse C; Alvarez L
Exp Parasitol; 2017 Oct; 181():23-29. PubMed ID: 28734749
[TBL] [Abstract][Full Text] [Related]
13. Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.
Gokbulut C; Cirak VY; Senlik B
Vet Res Commun; 2006 Oct; 30(7):791-805. PubMed ID: 17004041
[TBL] [Abstract][Full Text] [Related]
14. Albendazole sulphoxide enantiomeric ratios in plasma and target tissues after intravenous administration of ricobendazole to cattle.
Cristofol C; Virkel G; Alvarez L; Sánchez S; Arboix M; Lanusse C
J Vet Pharmacol Ther; 2001 Apr; 24(2):117-24. PubMed ID: 11442786
[TBL] [Abstract][Full Text] [Related]
15. Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.
Goudah A
Vet Res Commun; 2003 Oct; 27(7):555-66. PubMed ID: 14609267
[TBL] [Abstract][Full Text] [Related]
16. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep.
Novobilský A; Averpil HB; Höglund J
Vet Parasitol; 2012 Nov; 190(1-2):272-6. PubMed ID: 22818198
[TBL] [Abstract][Full Text] [Related]
17. Development of an egg hatch assay for the detection of anthelmintic resistance to albendazole in Fasciola hepatica isolated from sheep.
Robles-Pérez D; Martínez-Pérez JM; Rojo-Vázquez FA; Martínez-Valladares M
Vet Parasitol; 2014 Jun; 203(1-2):217-21. PubMed ID: 24576602
[TBL] [Abstract][Full Text] [Related]
18. Enhanced plasma and target tissue availabilities of albendazole and albendazole sulphoxide in fasted calves: evaluation of different fasting intervals.
Sánchez S; Alvarez L; Sallovitz J; Lanusse C
J Vet Pharmacol Ther; 2000 Aug; 23(4):193-201. PubMed ID: 11126322
[TBL] [Abstract][Full Text] [Related]
19. Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.
Novobilský A; Amaya Solis N; Skarin M; Höglund J
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):141-147. PubMed ID: 27380550
[TBL] [Abstract][Full Text] [Related]
20. A pharmacology-based comparison of the activity of albendazole and flubendazole against Echinococcus granulosus metacestode in sheep.
Ceballos L; Virkel G; Elissondo C; Canton C; Canevari J; Murno G; Denegri G; Lanusse C; Alvarez L
Acta Trop; 2013 Sep; 127(3):216-25. PubMed ID: 23692888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
